FSD Pharma Statistics
Total Valuation
FSD Pharma has a market cap or net worth of $5.59 million. The enterprise value is -$320,211.
| Market Cap | 5.59M |
| Enterprise Value | -320,211 |
Important Dates
The next estimated earnings date is Thursday, September 12, 2024, after market close.
| Earnings Date | Sep 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
FSD Pharma has 40.44 million shares outstanding. The number of shares has increased by 1.77% in one year.
| Shares Outstanding | 40.44M |
| Shares Change (YoY) | +1.77% |
| Shares Change (QoQ) | +0.73% |
| Owned by Insiders (%) | 12.61% |
| Owned by Institutions (%) | 2.89% |
| Float | 37.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.64 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.34 |
| Quick Ratio | 2.27 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -816.53 |
Financial Efficiency
Return on equity (ROE) is -70.80% and return on invested capital (ROIC) is -128.04%.
| Return on Equity (ROE) | -70.80% |
| Return on Assets (ROA) | -53.80% |
| Return on Capital (ROIC) | -128.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$425,953 |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.87% in the last 52 weeks. The beta is 0.99, so FSD Pharma's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | -87.87% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.72 |
| Relative Strength Index (RSI) | 29.81 |
| Average Volume (20 Days) | 2,524,497 |
Short Selling Information
The latest short interest is 98,469, so 0.24% of the outstanding shares have been sold short.
| Short Interest | 98,469 |
| Short Previous Month | 121,757 |
| Short % of Shares Out | 0.24% |
| Short % of Float | 0.26% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.79M |
| Pretax Income | -7.16M |
| Net Income | -7.24M |
| EBITDA | -6.07M |
| EBIT | -7.16M |
| Earnings Per Share (EPS) | -$0.19 |
Balance Sheet
The company has $6.37 million in cash and $453,797 in debt, giving a net cash position of $5.91 million or $0.15 per share.
| Cash & Cash Equivalents | 6.37M |
| Total Debt | 453,797 |
| Net Cash | 5.91M |
| Net Cash Per Share | $0.15 |
| Equity (Book Value) | 8.75M |
| Book Value Per Share | 0.22 |
| Working Capital | 3.83M |
Cash Flow
| Operating Cash Flow | -5.85M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.85M |
| FCF Per Share | -$0.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FSD Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.77% |
| Shareholder Yield | -1.77% |
| Earnings Yield | -129.48% |
| FCF Yield | -104.67% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 16, 2019. It was a reverse split with a ratio of 1:201.
| Last Split Date | Oct 16, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:201 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |